Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Bio-Rad Laboratories, Inc. (BIO) had Free Cash Flow per Share of $7.48 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$2.67B |
|
$-637.32M |
|
$1.24B |
|
$1.43B |
|
$2.33B |
|
$337.80M |
|
$-1.19B |
|
$-850.10M |
|
$402.15M |
|
$-637.32M |
|
$-637.32M |
|
$-637.32M |
|
$928.36M |
|
$337.80M |
|
$337.80M |
|
29.21M |
|
29.21M |
|
$-21.82 |
|
$-21.82 |
|
| Balance Sheet Financials | |
$3.05B |
|
$529.01M |
|
$9.25B |
|
$12.30B |
|
$522.80M |
|
$1.20B |
|
$3.04B |
|
$3.56B |
|
$8.74B |
|
$8.01B |
|
$8.74B |
|
28.52M |
|
| Cash Flow Statement Financials | |
$374.94M |
|
$20.21M |
|
$-425.65M |
|
$434.54M |
|
$404.37M |
|
$-30.18M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.83 |
|
-- |
|
-- |
|
0.12 |
|
0.14 |
|
53.42% |
|
12.65% |
|
12.65% |
|
12.65% |
|
-31.82% |
|
-23.86% |
|
$218.47M |
|
-- |
|
-- |
|
-- |
|
0.22 |
|
1.59 |
|
5.46 |
|
66.82 |
|
-7.29% |
|
-7.96% |
|
-5.18% |
|
-6.41% |
|
$306.50 |
|
|
Free Cash Flow per Share |
$7.48 |
$12.84 |
|